US Patent Issued to INIPHARM on Oct. 27 for "Thiazole HSD17B13 inhibitors and uses thereof" (American, Indian Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,278, issued on Oct. 27, was assigned to INIPHARM INC. (Bellevue, Wash.).

"Thiazole HSD17B13 inhibitors and uses thereof" was invented by Joshua Odingo (Bothell, Wash.), Sampath Kumar Anandan (Fremont, Calif.), Heather Kay Webb Hsu (Seattle), Vincent Florio (Seattle), Subramanyam Janardhan Tantry (Karnataka, India), Athisayamani Jeyaraj Duraiswamy (Karnataka, India) and Bharathi Mohan Kuppusamy (Karnataka, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are HSD17B13 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of liver disease, metaboli...